Keros Therapeutics, Inc. · NASDAQ:KROS

Bienaime Jean Jacques bought 1,000 Keros Therapeutics, Inc. shares (Form 4)

Traded Apr 15, 2026 · Filed Apr 17, 2026

On Apr 15, 2026, Bienaime Jean Jacques (Director) bought 1,000 Keros Therapeutics, Inc. shares at US$11.70 for US$11,700 under a trading plan, leaving 8,450 shares. Filed Apr 17, 2026 (Form 4).

Bought
1,000 shares
Price
US$11.70
Value
US$11,700
Holding after
8,450 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Apr 15, 2026Common StockBuy1,000US$11.708,450Direct

Source

View original at SEC

Related